Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Personalized tumor vaccine for pancreatic cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: February 23, 2022
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
Journal: British journal of haematology
Published: October 31, 2018
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism.
Journal: Journal of cellular and molecular medicine
Published: October 23, 2017
DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 30, 2017
MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs.
Journal: Leukemia
Published: November 30, 2016
Showing 1-5 of 5
Last Updated: 09/26/2026